Company news

Apyx Medical Corporation (NASDAQ:APYX) news

Apyx Medical Corporation news releases on 6ix. Latest, Sep 29, 2026: Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Apyx Medical Corporation (NASDAQ:APYX) news

Press releases & updates

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

APYX MEDICAL - NEW STUDY SHOWS SIGNIFICANT IMPROVEMENT IN CELLULITE AND SKIN LAXITY WITH ADVANCED MINIMALLY INVASIVE TREATMENT UTILIZING AVELI AND RENUVION

New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026

Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference

Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea

Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Apyx Medical Corporation Reports Third Quarter 2025 Financial Results

Apyx Medical Corporation to Participate in Upcoming November Investor Conferences

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction

Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025

Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference

Apyx Medical Corporation Announces Launch of Renuvion® in China

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025

Renuvion® Brings Real Transformations to the Runway at Miami Swim Week

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

Apyx Medical Corporation Reports First Quarter 2025 Financial Results

Renuvion Introduces Television Star Dolores Catania as Chief of Confidence

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health